Dr. Lecht is a visionary researcher and scientist with an entrepreneurial approach. He is an experienced multidisciplinary drug development leader. Dr. Lecht is an expert in cannabinoid-based product development including their effects and pharmacokinetic properties. As Chief Innovation Officer at Day Three Labs (DTL), Dr. Lecht brings along valuable experience in pre-clinical R&D, from early discovery, through formulations development to clinical trials.
Prior to joining DTL, Dr. Lecht took a leading part in multiple cannabis and botanical drug development projects, provided regulatory services to bio-tech start-up companies towards engagement with FDA, and founded a pharmaceutical consulting firm. Dr. Lecht completed post-doctoral training in Regenerative Medicine (Temple University, PA), holds an MSc and a PhD in Pharmacology from the Hebrew University in Jerusalem and is a licensed pharmacist (BScPharm, RPh) in Israel. Dr. Lecht has published numerous peer-reviewed publications and has presented at dozens of international meetings and conferences.